Schedule 13G ownership disclosure
MATINAS BIOPHARMA HLDGS INC
Security class unavailable · CUSIP: 576810105
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,483,771
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-19-000127
- Form type
- SC 13G
- Filer
- Lorenzo Jennifer
- CIK
- CIK 1697285
- Filed
- Feb 14, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership